EUVIMEDEUVIMED entdecken
Vergleichsstudie

Radiobiological model comparison of 3D conformal radiotherapy and IMRT plans for the treatment of prostate cancer

P Deb, A Fielding

Australasian Physics & Engineering Sciences in Medicine · 2009-06 · 32 (2) · 51-61

DOI: 10.1007/bf03178629 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Australasian Physics & Engineering Sciences in Medicine, 2009-06. Verfasst von P Deb und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Radiations, RMIT University, Bundoora, Australia. pradip.deb@rmit.edu.au. Hauptthemen laut MEDLINE: Models, Biological, Radiotherapy, Intensity-Modulated. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 40 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Models, BiologicalRadiotherapy, Intensity-ModulatedDose Fractionation, RadiationHumansMaleOrgan SizeOrgan SpecificityProstatic NeoplasmsRadiation Tolerance

Autor:innen und Institutionen

  • Department of Medical Radiations, RMIT University, Bundoora, Australia. pradip.deb@rmit.edu.au

Zitieren

APA

Deb, P., & Fielding, A. (2009). Radiobiological model comparison of 3D conformal radiotherapy and IMRT plans for the treatment of prostate cancer. Australasian Physics & Engineering Sciences in Medicine, 32(2), 51-61. https://doi.org/10.1007/bf03178629

Vancouver

Deb P, Fielding A. Radiobiological model comparison of 3D conformal radiotherapy and IMRT plans for the treatment of prostate cancer. Australasian Physics & Engineering Sciences in Medicine. 2009;32(2):51-61. doi:10.1007/bf03178629

BibTeX
@article{Deb2009,
  author = {Deb, P and Fielding, A},
  title = {Radiobiological model comparison of 3D conformal radiotherapy and IMRT plans for the treatment of prostate cancer},
  journal = {Australasian Physics & Engineering Sciences in Medicine},
  year = {2009},
  volume = {32},
  number = {2},
  pages = {51--61},
  doi = {10.1007/bf03178629}
}
Kostenlos starten →